FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967269886> ?p ?o ?g. }

• W1967269886 endingPage "57" @default.
• W1967269886 startingPage "47" @default.
• W1967269886 abstract "Cisplatin chemotherapy is associated with an increased risk of ototoxic changes. The incidence of hearing loss after the 1st cisplatin-infusion session is only scarcely mentioned in the international literature. With increasing survival rates, prevention and/or early detection of ototoxicity are important for providing management options. The predictive value of pure-tone audiometry in early detection of ototoxicity has been questioned, particularly in the higher frequencies. Otoacoustic emissions appear to be more sensitive to cochlear insult than the conventional pure-tone audiometry. The aims of our study was (a) to define the extent of hearing damage in children after the 1st cisplatin-infusion session (50 mg/m(2)); and (b) to compare the efficacy of otoacoustic emissions (transient evoked otoacoustic emissions, distortion-product otoacoustic emissions) with that of pure-tone audiometry as methods of audiological monitoring.Baseline audiometric (0.25-8 kHz) and otoacoustic emission testing (transient evoked otoacoustic emissions, distortion-product otoacoustic emissions) was conducted in 19 children, 12 of whom met the criteria for inclusion in the final study. Comparisons were performed between baseline measurements and those recorded after the 1st cisplatin course. Transient evoked otoacoustic emissions were analyzed in terms of emission level and reproducibility as a function of frequency (0.8-4 kHz). Distortion-product otoacoustic emissions were obtained as DP-grams and I/Q functions at 4,6 and 8 kHz. The DP-gram amplitude, the dynamic range and the detection thresholds from the I/Q functions were determined for each child.Threshold changes from baseline were founded to be statistically significant from 4-8 kHz in 50% of the children (P<0.01). Transient evoked otoacoustic emissions revealed a significant decrease in the emission level and in the reproducibility at the highest frequency tested (4 kHz, P<0.01), reflecting the results seen in pure-tone audiometry. Distortion-product otoacoustic emissions demonstrated a significant threshold shift, a reduced dynamic range and a decreased amplitude in the frequencies >3 kHz (P<0.05). Furthermore, DP-gram amplitude also reduced significantly at 3 kHz (P<0.05) without any similar change in pure-tone audiometry.A significant high-frequency hearing loss is identified in children even after one low-dose cisplatin-infusion session. As ototoxicity screening tools DP-grams were extremely sensitive and superior to pure-tone audiometry and/or transient evoked otoacoustic emissions. Their use is recommended for regular monitoring of cochlear function, aiming in prevention of permanent damage. Some suggestions for reducing the potential for cisplatin ototoxicity (chemoprotective agents, gene therapy, inhibition of apoptosis) are also discussed." @default.
• W1967269886 created "2016-06-24" @default.
• W1967269886 creator A5010281153 @default.
• W1967269886 creator A5014758465 @default.
• W1967269886 creator A5032683587 @default.
• W1967269886 creator A5042172463 @default.
• W1967269886 creator A5090260737 @default.
• W1967269886 date "2001-05-01" @default.
• W1967269886 modified "2023-10-07" @default.
• W1967269886 title "Evoked otoacoustic emissions — an approach for monitoring cisplatin induced ototoxicity in children" @default.
• W1967269886 cites W1977242290 @default.
• W1967269886 cites W1983019584 @default.
• W1967269886 cites W1989838308 @default.
• W1967269886 cites W1991097350 @default.
• W1967269886 cites W1992121983 @default.
• W1967269886 cites W1998147719 @default.
• W1967269886 cites W2005082783 @default.
• W1967269886 cites W2006459427 @default.
• W1967269886 cites W2010036821 @default.
• W1967269886 cites W2014900175 @default.
• W1967269886 cites W2026869404 @default.
• W1967269886 cites W2037443654 @default.
• W1967269886 cites W2042320307 @default.
• W1967269886 cites W2048490699 @default.
• W1967269886 cites W2064337652 @default.
• W1967269886 cites W2089607531 @default.
• W1967269886 cites W2093262643 @default.
• W1967269886 cites W2113735297 @default.
• W1967269886 cites W2124570870 @default.
• W1967269886 cites W2164816755 @default.
• W1967269886 cites W2215439213 @default.
• W1967269886 cites W2316519844 @default.
• W1967269886 cites W2383979465 @default.
• W1967269886 cites W44501803 @default.
• W1967269886 doi "https://doi.org/10.1016/s0165-5876(01)00455-4" @default.
• W1967269886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11376818" @default.
• W1967269886 hasPublicationYear "2001" @default.
• W1967269886 type Work @default.
• W1967269886 sameAs 1967269886 @default.
• W1967269886 citedByCount "89" @default.
• W1967269886 countsByYear W19672698862012 @default.
• W1967269886 countsByYear W19672698862013 @default.
• W1967269886 countsByYear W19672698862014 @default.
• W1967269886 countsByYear W19672698862015 @default.
• W1967269886 countsByYear W19672698862016 @default.
• W1967269886 countsByYear W19672698862017 @default.
• W1967269886 countsByYear W19672698862018 @default.
• W1967269886 countsByYear W19672698862019 @default.
• W1967269886 countsByYear W19672698862020 @default.
• W1967269886 countsByYear W19672698862021 @default.
• W1967269886 countsByYear W19672698862023 @default.
• W1967269886 crossrefType "journal-article" @default.
• W1967269886 hasAuthorship W1967269886A5010281153 @default.
• W1967269886 hasAuthorship W1967269886A5014758465 @default.
• W1967269886 hasAuthorship W1967269886A5032683587 @default.
• W1967269886 hasAuthorship W1967269886A5042172463 @default.
• W1967269886 hasAuthorship W1967269886A5090260737 @default.
• W1967269886 hasConcept C141071460 @default.
• W1967269886 hasConcept C2776694085 @default.
• W1967269886 hasConcept C2778239845 @default.
• W1967269886 hasConcept C2778534666 @default.
• W1967269886 hasConcept C2780130748 @default.
• W1967269886 hasConcept C2780493683 @default.
• W1967269886 hasConcept C2780554537 @default.
• W1967269886 hasConcept C2780941679 @default.
• W1967269886 hasConcept C2781383708 @default.
• W1967269886 hasConcept C548259974 @default.
• W1967269886 hasConcept C71924100 @default.
• W1967269886 hasConceptScore W1967269886C141071460 @default.
• W1967269886 hasConceptScore W1967269886C2776694085 @default.
• W1967269886 hasConceptScore W1967269886C2778239845 @default.
• W1967269886 hasConceptScore W1967269886C2778534666 @default.
• W1967269886 hasConceptScore W1967269886C2780130748 @default.
• W1967269886 hasConceptScore W1967269886C2780493683 @default.
• W1967269886 hasConceptScore W1967269886C2780554537 @default.
• W1967269886 hasConceptScore W1967269886C2780941679 @default.
• W1967269886 hasConceptScore W1967269886C2781383708 @default.
• W1967269886 hasConceptScore W1967269886C548259974 @default.
• W1967269886 hasConceptScore W1967269886C71924100 @default.
• W1967269886 hasIssue "1" @default.
• W1967269886 hasLocation W19672698861 @default.
• W1967269886 hasLocation W19672698862 @default.
• W1967269886 hasOpenAccess W1967269886 @default.
• W1967269886 hasPrimaryLocation W19672698861 @default.
• W1967269886 hasRelatedWork W1967269886 @default.
• W1967269886 hasRelatedWork W1967382436 @default.
• W1967269886 hasRelatedWork W2012077160 @default.
• W1967269886 hasRelatedWork W2059577689 @default.
• W1967269886 hasRelatedWork W2156234545 @default.
• W1967269886 hasRelatedWork W2315422235 @default.
• W1967269886 hasRelatedWork W2363308234 @default.
• W1967269886 hasRelatedWork W2389550265 @default.
• W1967269886 hasRelatedWork W2410849397 @default.
• W1967269886 hasRelatedWork W2552433917 @default.
• W1967269886 hasVolume "59" @default.
• W1967269886 isParatext "false" @default.
• W1967269886 isRetracted "false" @default.
• W1967269886 magId "1967269886" @default.

• next